Thiopurines and non-melanoma skin cancer: partners in crime in inflammatory bowel diseases.

Date publication

novembre 2020

Journal

British medical bulletin

Auteurs

Membres identifiés du Cancéropôle Est :
Pr PEYRIN-BIROULET Laurent

Tous les auteurs :
Solitano V, D'Amico F, Correale C, Peyrin-Biroulet L, Danese S

Lien Pubmed

http://www.ncbi.nlm.nih.gov/pubmed/33200781

Résumé

Several studies have shown that inflammatory bowel diseases (IBD) patients treated with thiopurines have an increased risk of developing skin cancer.

Mots clés

inflammatory bowel diseases, nonmelanoma skin cancer, thiopurines

Référence

Br Med Bull. 2020 Nov 16;: